APO Research
Talk to an analyst

APO RESEARCH · REPORT

Percutaneous Coronary Intervention (PCI) Treatment Instruments

Compare research editions
View pricing & licenses

Selected research

Industry Research

Percutaneous Coronary Intervention (PCI) Treatment Instruments Industry Research Report 2026

24 December 2025141 pages

Choose your research edition.

Industry ResearchPercutaneous Coronary Intervention (PCI) Treatment Instruments Industry Research Report 2026141 pages · $2,950 USDIndustry Growth & TrendsGlobal Percutaneous Coronary Intervention (PCI) Treatment Instruments Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Percutaneous Coronary Intervention (PCI) Treatment Instruments Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Outlook and Growth Opportunities 2026218 pages · $4,250 USDMarket Analysis & ForecastGlobal Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Analysis and Forecast 2026-2032215 pages · $4,950 USD

Market perspective

The global Percutaneous Coronary Intervention (PCI) Treatment Instruments market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

North America: the Percutaneous Coronary Intervention (PCI) Treatment Instruments market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Percutaneous Coronary Intervention (PCI) Treatment Instruments market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Percutaneous Coronary Intervention (PCI) Treatment Instruments market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Percutaneous Coronary Intervention (PCI) Treatment Instruments include Medtronic, OrbusNeich Medical Company, MicroPort Scientific Corporation, Suzhou Innomed Medical Device, Shunmei Medical, Shanghai INT Medical Instruments, Lepu Medical Technology, APT Medical and BrosMed Medical, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

Read the full market overview

This report quantifies the global Percutaneous Coronary Intervention (PCI) Treatment Instruments market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Percutaneous Coronary Intervention (PCI) Treatment Instruments.

Key Companies & Market Share Insights

This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Percutaneous Coronary Intervention (PCI) Treatment Instruments Market by Company

Medtronic

OrbusNeich Medical Company

MicroPort Scientific Corporation

Suzhou Innomed Medical Device

Shunmei Medical

Shanghai INT Medical Instruments

Lepu Medical Technology

APT Medical

BrosMed Medical

Terumo Corporation

QualiMe

Merit Medical

Curatia Medical

Cordis

Cardionovum

Boston Scientific

ASAHI INTECC

Abbott

Zhejiang Barty Medical Technology

Shenzhen MicroApproach Medical Technology

Beijing Demax Medical Technology

JW Medical Systems

SINOMED

Kinhely Bio-Tech

Shandong Huaan Biotechnology

Blue Sail Medical

Shanghai Bio-heart Biological Technology

Percutaneous Coronary Intervention (PCI) Treatment Instruments Segment by Type

Coronary Pathway Assistive Instruments

Interventional Treatment Instruments

Percutaneous Coronary Intervention (PCI) Treatment Instruments Segment by Application

Hospital

Clinic

Others

Percutaneous Coronary Intervention (PCI) Treatment Instruments Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Russia

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Saudi Arabia

Israel

United Arab Emirates

Turkey

Iran

Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Percutaneous Coronary Intervention (PCI) Treatment Instruments market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Percutaneous Coronary Intervention (PCI) Treatment Instruments and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Percutaneous Coronary Intervention (PCI) Treatment Instruments.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Percutaneous Coronary Intervention (PCI) Treatment Instruments companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size by Type (2021-2026) & (US$ Million) Table 6. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue Market Share by Type (2021-2026) Table 7. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Forecasted Market Size by Type (2027-2032) & (US$ Million) Table 8. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue Market Share by Type (2027-2032) Table 9. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size by Application (2021-2026) & (US$ Million) Table 10. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue Market Share by Application (2021-2026) Table 11. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Forecasted Market Size by Application (2027-2032) & (US$ Million) Table 12. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue Market Share by Application (2027-2032) Table 13. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Share by Region (2021-2026) Table 16. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Forecasted Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Share by Region (2027-2032) Table 18. Percutaneous Coronary Intervention (PCI) Treatment Instruments Industry Trends Table 19. Percutaneous Coronary Intervention (PCI) Treatment Instruments Industry Drivers Table 20. Percutaneous Coronary Intervention (PCI) Treatment Instruments Industry Opportunities and Challenges Table 21. Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Restraints Table 22. Global Top Percutaneous Coronary Intervention (PCI) Treatment Instruments Players by Revenue (US$ Million) & (2021-2026) Table 23. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue Market Share by Players (2021-2026) Table 24. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Industry Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Key Players of Percutaneous Coronary Intervention (PCI) Treatment Instruments, Headquarters and Area Served Table 26. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Players, Product Type & Application Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Players Mergers & Acquisitions, Expansion Plans Table 30. North America Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 31. North America Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size by Country (2021-2026) & (US$ Million) Table 32. North America Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size by Country (2027-2032) & (US$ Million) Table 33. Europe Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Europe Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size by Country (2021-2026) & (US$ Million) Table 35. Europe Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size by Country (2027-2032) & (US$ Million) Table 36. Asia Pacific Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Asia Pacific Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size by Region (2021-2026) & (US$ Million) Table 38. Asia Pacific Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size by Country (2027-2032) & (US$ Million) Table 39. South America Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. South America Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size by Country (2021-2026) & (US$ Million) Table 41. South America Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size by Country (2027-2032) & (US$ Million) Table 42. Middle East & Africa Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Middle East & Africa Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size by Country (2021-2026) & (US$ Million) Table 44. Middle East & Africa Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size by Country (2027-2032) & (US$ Million) Table 45. Medtronic Company Information Table 46. Medtronic Business Overview Table 47. Medtronic Revenue in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026) & (US$ Million) Table 48. Medtronic Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 49. Medtronic Recent Developments Table 50. OrbusNeich Medical Company Company Information Table 51. OrbusNeich Medical Company Business Overview Table 52. OrbusNeich Medical Company Revenue in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026) & (US$ Million) Table 53. OrbusNeich Medical Company Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 54. OrbusNeich Medical Company Recent Developments Table 55. MicroPort Scientific Corporation Company Information Table 56. MicroPort Scientific Corporation Business Overview Table 57. MicroPort Scientific Corporation Revenue in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026) & (US$ Million) Table 58. MicroPort Scientific Corporation Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 59. MicroPort Scientific Corporation Recent Developments Table 60. Suzhou Innomed Medical Device Company Information Table 61. Suzhou Innomed Medical Device Business Overview Table 62. Suzhou Innomed Medical Device Revenue in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026) & (US$ Million) Table 63. Suzhou Innomed Medical Device Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 64. Suzhou Innomed Medical Device Recent Developments Table 65. Shunmei Medical Company Information Table 66. Shunmei Medical Business Overview Table 67. Shunmei Medical Revenue in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026) & (US$ Million) Table 68. Shunmei Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 69. Shunmei Medical Recent Developments Table 70. Shanghai INT Medical Instruments Company Information Table 71. Shanghai INT Medical Instruments Business Overview Table 72. Shanghai INT Medical Instruments Revenue in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026) & (US$ Million) Table 73. Shanghai INT Medical Instruments Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 74. Shanghai INT Medical Instruments Recent Developments Table 75. Lepu Medical Technology Company Information Table 76. Lepu Medical Technology Business Overview Table 77. Lepu Medical Technology Revenue in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026) & (US$ Million) Table 78. Lepu Medical Technology Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 79. Lepu Medical Technology Recent Developments Table 80. APT Medical Company Information Table 81. APT Medical Business Overview Table 82. APT Medical Revenue in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026) & (US$ Million) Table 83. APT Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 84. APT Medical Recent Developments Table 85. BrosMed Medical Company Information Table 86. BrosMed Medical Business Overview Table 87. BrosMed Medical Revenue in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026) & (US$ Million) Table 88. BrosMed Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 89. BrosMed Medical Recent Developments Table 90. Terumo Corporation Company Information Table 91. Terumo Corporation Business Overview Table 92. Terumo Corporation Revenue in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026) & (US$ Million) Table 93. Terumo Corporation Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 94. Terumo Corporation Recent Developments Table 95. QualiMe Company Information Table 96. QualiMe Business Overview Table 97. QualiMe Revenue in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026) & (US$ Million) Table 98. QualiMe Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 99. QualiMe Recent Developments Table 100. Merit Medical Company Information Table 101. Merit Medical Business Overview Table 102. Merit Medical Revenue in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026) & (US$ Million) Table 103. Merit Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 104. Merit Medical Recent Developments Table 105. Curatia Medical Company Information Table 106. Curatia Medical Business Overview Table 107. Curatia Medical Revenue in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026) & (US$ Million) Table 108. Curatia Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 109. Curatia Medical Recent Developments Table 110. Cordis Company Information Table 111. Cordis Business Overview Table 112. Cordis Revenue in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026) & (US$ Million) Table 113. Cordis Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 114. Cordis Recent Developments Table 115. Cardionovum Company Information Table 116. Cardionovum Business Overview Table 117. Cardionovum Revenue in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026) & (US$ Million) Table 118. Cardionovum Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 119. Cardionovum Recent Developments Table 120. Boston Scientific Company Information Table 121. Boston Scientific Business Overview Table 122. Boston Scientific Revenue in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026) & (US$ Million) Table 123. Boston Scientific Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 124. Boston Scientific Recent Developments Table 125. ASAHI INTECC Company Information Table 126. ASAHI INTECC Business Overview Table 127. ASAHI INTECC Revenue in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026) & (US$ Million) Table 128. ASAHI INTECC Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 129. ASAHI INTECC Recent Developments Table 130. Abbott Company Information Table 131. Abbott Business Overview Table 132. Abbott Revenue in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026) & (US$ Million) Table 133. Abbott Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 134. Abbott Recent Developments Table 135. Zhejiang Barty Medical Technology Company Information Table 136. Zhejiang Barty Medical Technology Business Overview Table 137. Zhejiang Barty Medical Technology Revenue in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026) & (US$ Million) Table 138. Zhejiang Barty Medical Technology Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 139. Zhejiang Barty Medical Technology Recent Developments Table 140. Shenzhen MicroApproach Medical Technology Company Information Table 141. Shenzhen MicroApproach Medical Technology Business Overview Table 142. Shenzhen MicroApproach Medical Technology Revenue in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026) & (US$ Million) Table 143. Shenzhen MicroApproach Medical Technology Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 144. Shenzhen MicroApproach Medical Technology Recent Developments Table 145. Beijing Demax Medical Technology Company Information Table 146. Beijing Demax Medical Technology Business Overview Table 147. Beijing Demax Medical Technology Revenue in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026) & (US$ Million) Table 148. Beijing Demax Medical Technology Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 149. Beijing Demax Medical Technology Recent Developments Table 150. JW Medical Systems Company Information Table 151. JW Medical Systems Business Overview Table 152. JW Medical Systems Revenue in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026) & (US$ Million) Table 153. JW Medical Systems Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 154. JW Medical Systems Recent Developments Table 155. SINOMED Company Information Table 156. SINOMED Business Overview Table 157. SINOMED Revenue in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026) & (US$ Million) Table 158. SINOMED Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 159. SINOMED Recent Developments Table 160. Kinhely Bio-Tech Company Information Table 161. Kinhely Bio-Tech Business Overview Table 162. Kinhely Bio-Tech Revenue in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026) & (US$ Million) Table 163. Kinhely Bio-Tech Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 164. Kinhely Bio-Tech Recent Developments Table 165. Shandong Huaan Biotechnology Company Information Table 166. Shandong Huaan Biotechnology Business Overview Table 167. Shandong Huaan Biotechnology Revenue in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026) & (US$ Million) Table 168. Shandong Huaan Biotechnology Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 169. Shandong Huaan Biotechnology Recent Developments Table 170. Blue Sail Medical Company Information Table 171. Blue Sail Medical Business Overview Table 172. Blue Sail Medical Revenue in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026) & (US$ Million) Table 173. Blue Sail Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 174. Blue Sail Medical Recent Developments Table 175. Shanghai Bio-heart Biological Technology Company Information Table 176. Shanghai Bio-heart Biological Technology Business Overview Table 177. Shanghai Bio-heart Biological Technology Revenue in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026) & (US$ Million) Table 178. Shanghai Bio-heart Biological Technology Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 179. Shanghai Bio-heart Biological Technology Recent Developments Table 180. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Image Figure 5. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Share by Type: 2025 VS 2032 Figure 7. Coronary Pathway Assistive Instruments Product Figure 8. Interventional Treatment Instruments Product Figure 9. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Share by Application: 2025 VS 2032 Figure 11. Hospital Product Figure 12. Clinic Product Figure 13. Others Product Figure 14. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size (US$ Million), Year-over-Year: 2021-2032 Figure 15. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Share by Region: 2025 VS 2032 Figure 17. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Share by Players in 2025 Figure 18. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Manufacturers Established Date Figure 19. Global Top 5 and 10 Percutaneous Coronary Intervention (PCI) Treatment Instruments Players Market Share by Revenue in 2025 Figure 20. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. North America Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Share by Country (2021-2032) Figure 23. United States Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size YoY Growth (2021-2032) & (US$ Million) Figure 24. Canada Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Mexico Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Share by Country (2021-2032) Figure 26. Europe Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Europe Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Share by Country (2021-2032) Figure 28. Germany Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. France Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size YoY Growth (2021-2032) & (US$ Million) Figure 30. U.K. Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Italy Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size YoY Growth (2021-2032) & (US$ Million) Figure 32. Spain Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Russia Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size YoY Growth (2021-2032) & (US$ Million) Figure 34. Netherlands Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Nordic Countries Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size YoY Growth (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Share by Country (2021-2032) Figure 38. China Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Japan Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size YoY Growth (2021-2032) & (US$ Million) Figure 40. South Korea Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. India Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size YoY Growth (2021-2032) & (US$ Million) Figure 42. India Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Share by Country (2021-2032) Figure 43. Australia Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size YoY Growth (2021-2032) & (US$ Million) Figure 44. China Taiwan Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size YoY Growth (2021-2032) & (US$ Million) Figure 45. Southeast Asia Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size YoY Growth (2021-2032) & (US$ Million) Figure 46. South America Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size YoY Growth (2021-2032) & (US$ Million) Figure 47. South America Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Share by Country (2021-2032) Figure 48. Brazil Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size YoY Growth (2021-2032) & (US$ Million) Figure 49. Argentina Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size YoY Growth (2021-2032) & (US$ Million) Figure 50. Chile Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size YoY Growth (2021-2032) & (US$ Million) Figure 51. Colombia Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size YoY Growth (2021-2032) & (US$ Million) Figure 52. Peru Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size YoY Growth (2021-2032) & (US$ Million) Figure 53. Medtronic Revenue Growth Rate in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026) Figure 54. OrbusNeich Medical Company Revenue Growth Rate in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026) Figure 55. MicroPort Scientific Corporation Revenue Growth Rate in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026) Figure 56. Suzhou Innomed Medical Device Revenue Growth Rate in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026) Figure 57. Shunmei Medical Revenue Growth Rate in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026) Figure 58. Shanghai INT Medical Instruments Revenue Growth Rate in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026) Figure 59. Lepu Medical Technology Revenue Growth Rate in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026) Figure 60. APT Medical Revenue Growth Rate in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026) Figure 61. BrosMed Medical Revenue Growth Rate in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026) Figure 62. Terumo Corporation Revenue Growth Rate in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026) Figure 63. QualiMe Revenue Growth Rate in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026) Figure 64. Merit Medical Revenue Growth Rate in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026) Figure 65. Curatia Medical Revenue Growth Rate in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026) Figure 66. Cordis Revenue Growth Rate in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026) Figure 67. Cardionovum Revenue Growth Rate in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026) Figure 68. Boston Scientific Revenue Growth Rate in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026) Figure 69. ASAHI INTECC Revenue Growth Rate in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026) Figure 70. Abbott Revenue Growth Rate in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026) Figure 71. Zhejiang Barty Medical Technology Revenue Growth Rate in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026) Figure 72. Shenzhen MicroApproach Medical Technology Revenue Growth Rate in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026) Figure 73. Beijing Demax Medical Technology Revenue Growth Rate in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026) Figure 74. JW Medical Systems Revenue Growth Rate in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026) Figure 75. SINOMED Revenue Growth Rate in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026) Figure 76. Kinhely Bio-Tech Revenue Growth Rate in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026) Figure 77. Shandong Huaan Biotechnology Revenue Growth Rate in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026) Figure 78. Blue Sail Medical Revenue Growth Rate in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026) Figure 79. Shanghai Bio-heart Biological Technology Revenue Growth Rate in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026)

Scope & coverage.

Types
  • Coronary Pathway Assistive Instruments
  • Interventional Treatment Instruments
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Medtronic
  • OrbusNeich Medical Company
  • MicroPort Scientific Corporation
  • Suzhou Innomed Medical Device
  • Shunmei Medical
  • Shanghai INT Medical Instruments
  • Lepu Medical Technology
  • APT Medical
  • BrosMed Medical
  • Terumo Corporation
  • QualiMe
  • Merit Medical
  • Curatia Medical
  • Cordis
  • Cardionovum
  • Boston Scientific
  • ASAHI INTECC
  • Abbott
  • Zhejiang Barty Medical Technology
  • Shenzhen MicroApproach Medical Technology
  • Beijing Demax Medical Technology
  • JW Medical Systems
  • SINOMED
  • Kinhely Bio-Tech
  • Shandong Huaan Biotechnology
  • Blue Sail Medical
  • Shanghai Bio-heart Biological Technology

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Percutaneous Coronary Intervention (PCI) Treatment Instruments by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
  4. 2.2.2 Coronary Pathway Assistive Instruments
  5. 2.2.3 Interventional Treatment Instruments
  6. 2.3 Percutaneous Coronary Intervention (PCI) Treatment Instruments by Application
  7. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  8. 2.3.2 Hospital
  9. 2.3.3 Clinic
  10. 2.3.4 Others
  11. 2.4 Assumptions and Limitations
3 Percutaneous Coronary Intervention (PCI) Treatment Instruments Breakdown Data by Type
  1. 3.1 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Historic Market Size by Type (2021-2026)
  2. 3.2 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Forecasted Market Size by Type (2027-2032)
4 Percutaneous Coronary Intervention (PCI) Treatment Instruments Breakdown Data by Application
  1. 4.1 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Historic Market Size by Application (2021-2026)
  2. 4.2 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
  1. 5.1 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Perspective (2021-2032)
  2. 5.2 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Growth Trends by Region
  3. 5.2.1 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size by Region: 2021 VS 2025 VS 2032
  4. 5.2.2 Percutaneous Coronary Intervention (PCI) Treatment Instruments Historic Market Size by Region (2021-2026)
  5. 5.2.3 Percutaneous Coronary Intervention (PCI) Treatment Instruments Forecasted Market Size by Region (2027-2032)
  6. 5.3 Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Dynamics
  7. 5.3.1 Percutaneous Coronary Intervention (PCI) Treatment Instruments Industry Trends
  8. 5.3.2 Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Drivers
  9. 5.3.3 Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Challenges
  10. 5.3.4 Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Restraints
6 Market Competitive Landscape by Players
  1. 6.1 Global Top Percutaneous Coronary Intervention (PCI) Treatment Instruments Players by Revenue
  2. 6.1.1 Global Top Percutaneous Coronary Intervention (PCI) Treatment Instruments Players by Revenue (2021-2026)
  3. 6.1.2 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue Market Share by Players (2021-2026)
  4. 6.2 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Industry Players Ranking, 2023 VS 2024 VS 2025
  5. 6.3 Global Key Players of Percutaneous Coronary Intervention (PCI) Treatment Instruments Head Office and Area Served
  6. 6.4 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Players, Product Type & Application
  7. 6.5 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Manufacturers Established Date
  8. 6.6 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Market CR5 and HHI
  9. 6.7 Global Players Mergers & Acquisition
7 North America
  1. 7.1 North America Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size (2021-2032)
  2. 7.2 North America Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 7.3 North America Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size by Country (2021-2026)
  4. 7.4 North America Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size by Country (2027-2032)
  5. 7.5 United States
  6. 7.5 United States
  7. 7.6 Canada
  8. 7.7 Mexico
8 Europe
  1. 8.1 Europe Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size (2021-2032)
  2. 8.2 Europe Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 8.3 Europe Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size by Country (2021-2026)
  4. 8.4 Europe Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size by Country (2027-2032)
  5. 8.5 Germany
  6. 8.6 France
  7. 8.7 U.K.
  8. 8.8 Italy
  9. 8.9 Spain
  10. 8.10 Russia
  11. 8.11 Netherlands
  12. 8.12 Nordic Countries
9 Asia-Pacific
  1. 9.1 Asia-Pacific Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size (2021-2032)
  2. 9.2 Asia-Pacific Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 9.3 Asia-Pacific Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size by Country (2021-2026)
  4. 9.4 Asia-Pacific Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size by Country (2027-2032)
  5. 9.5 China
  6. 9.6 Japan
  7. 9.7 South Korea
  8. 9.8 India
  9. 9.9 Australia
  10. 9.10 China Taiwan
  11. 9.11 Southeast Asia
10 South America
  1. 10.1 South America Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size (2021-2032)
  2. 10.2 South America Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 10.3 South America Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size by Country (2021-2026)
  4. 10.4 South America Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size by Country (2027-2032)
  5. 10.5 Brazil
  6. 10.6 Argentina
  7. 10.7 Chile
  8. 10.8 Colombia
  9. 10.9 Peru
11 Middle East & Africa
  1. 11.1 Middle East & Africa Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size (2021-2032)
  2. 11.2 Middle East & Africa Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 11.3 Middle East & Africa Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size by Country (2021-2026)
  4. 11.4 Middle East & Africa Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size by Country (2027-2032)
  5. 11.5 Saudi Arabia
  6. 11.6 Israel
  7. 11.7 United Arab Emirates
  8. 11.8 Turkey
  9. 11.9 Iran
  10. 11.10 Egypt
12 Players Profiled
  1. 12.1 Medtronic
  2. 12.1.1 Medtronic Company Information
  3. 12.1.2 Medtronic Business Overview
  4. 12.1.3 Medtronic Revenue in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026)
  5. 12.1.4 Medtronic Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  6. 12.1.5 Medtronic Recent Developments
  7. 12.2 OrbusNeich Medical Company
  8. 12.2.1 OrbusNeich Medical Company Company Information
  9. 12.2.2 OrbusNeich Medical Company Business Overview
  10. 12.2.3 OrbusNeich Medical Company Revenue in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026)
  11. 12.2.4 OrbusNeich Medical Company Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  12. 12.2.5 OrbusNeich Medical Company Recent Developments
  13. 12.3 MicroPort Scientific Corporation
  14. 12.3.1 MicroPort Scientific Corporation Company Information
  15. 12.3.2 MicroPort Scientific Corporation Business Overview
  16. 12.3.3 MicroPort Scientific Corporation Revenue in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026)
  17. 12.3.4 MicroPort Scientific Corporation Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  18. 12.3.5 MicroPort Scientific Corporation Recent Developments
  19. 12.4 Suzhou Innomed Medical Device
  20. 12.4.1 Suzhou Innomed Medical Device Company Information
  21. 12.4.2 Suzhou Innomed Medical Device Business Overview
  22. 12.4.3 Suzhou Innomed Medical Device Revenue in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026)
  23. 12.4.4 Suzhou Innomed Medical Device Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  24. 12.4.5 Suzhou Innomed Medical Device Recent Developments
  25. 12.5 Shunmei Medical
  26. 12.5.1 Shunmei Medical Company Information
  27. 12.5.2 Shunmei Medical Business Overview
  28. 12.5.3 Shunmei Medical Revenue in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026)
  29. 12.5.4 Shunmei Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  30. 12.5.5 Shunmei Medical Recent Developments
  31. 12.6 Shanghai INT Medical Instruments
  32. 12.6.1 Shanghai INT Medical Instruments Company Information
  33. 12.6.2 Shanghai INT Medical Instruments Business Overview
  34. 12.6.3 Shanghai INT Medical Instruments Revenue in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026)
  35. 12.6.4 Shanghai INT Medical Instruments Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  36. 12.6.5 Shanghai INT Medical Instruments Recent Developments
  37. 12.7 Lepu Medical Technology
  38. 12.7.1 Lepu Medical Technology Company Information
  39. 12.7.2 Lepu Medical Technology Business Overview
  40. 12.7.3 Lepu Medical Technology Revenue in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026)
  41. 12.7.4 Lepu Medical Technology Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  42. 12.7.5 Lepu Medical Technology Recent Developments
  43. 12.8 APT Medical
  44. 12.8.1 APT Medical Company Information
  45. 12.8.2 APT Medical Business Overview
  46. 12.8.3 APT Medical Revenue in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026)
  47. 12.8.4 APT Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  48. 12.8.5 APT Medical Recent Developments
  49. 12.9 BrosMed Medical
  50. 12.9.1 BrosMed Medical Company Information
  51. 12.9.2 BrosMed Medical Business Overview
  52. 12.9.3 BrosMed Medical Revenue in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026)
  53. 12.9.4 BrosMed Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  54. 12.9.5 BrosMed Medical Recent Developments
  55. 12.10 Terumo Corporation
  56. 12.10.1 Terumo Corporation Company Information
  57. 12.10.2 Terumo Corporation Business Overview
  58. 12.10.3 Terumo Corporation Revenue in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026)
  59. 12.10.4 Terumo Corporation Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  60. 12.10.5 Terumo Corporation Recent Developments
  61. 12.11 QualiMe
  62. 12.11.1 QualiMe Company Information
  63. 12.11.2 QualiMe Business Overview
  64. 12.11.3 QualiMe Revenue in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026)
  65. 12.11.4 QualiMe Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  66. 12.11.5 QualiMe Recent Developments
  67. 12.12 Merit Medical
  68. 12.12.1 Merit Medical Company Information
  69. 12.12.2 Merit Medical Business Overview
  70. 12.12.3 Merit Medical Revenue in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026)
  71. 12.12.4 Merit Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  72. 12.12.5 Merit Medical Recent Developments
  73. 12.13 Curatia Medical
  74. 12.13.1 Curatia Medical Company Information
  75. 12.13.2 Curatia Medical Business Overview
  76. 12.13.3 Curatia Medical Revenue in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026)
  77. 12.13.4 Curatia Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  78. 12.13.5 Curatia Medical Recent Developments
  79. 12.14 Cordis
  80. 12.14.1 Cordis Company Information
  81. 12.14.2 Cordis Business Overview
  82. 12.14.3 Cordis Revenue in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026)
  83. 12.14.4 Cordis Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  84. 12.14.5 Cordis Recent Developments
  85. 12.15 Cardionovum
  86. 12.15.1 Cardionovum Company Information
  87. 12.15.2 Cardionovum Business Overview
  88. 12.15.3 Cardionovum Revenue in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026)
  89. 12.15.4 Cardionovum Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  90. 12.15.5 Cardionovum Recent Developments
  91. 12.16 Boston Scientific
  92. 12.16.1 Boston Scientific Company Information
  93. 12.16.2 Boston Scientific Business Overview
  94. 12.16.3 Boston Scientific Revenue in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026)
  95. 12.16.4 Boston Scientific Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  96. 12.16.5 Boston Scientific Recent Developments
  97. 12.17 ASAHI INTECC
  98. 12.17.1 ASAHI INTECC Company Information
  99. 12.17.2 ASAHI INTECC Business Overview
  100. 12.17.3 ASAHI INTECC Revenue in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026)
  101. 12.17.4 ASAHI INTECC Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  102. 12.17.5 ASAHI INTECC Recent Developments
  103. 12.18 Abbott
  104. 12.18.1 Abbott Company Information
  105. 12.18.2 Abbott Business Overview
  106. 12.18.3 Abbott Revenue in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026)
  107. 12.18.4 Abbott Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  108. 12.18.5 Abbott Recent Developments
  109. 12.19 Zhejiang Barty Medical Technology
  110. 12.19.1 Zhejiang Barty Medical Technology Company Information
  111. 12.19.2 Zhejiang Barty Medical Technology Business Overview
  112. 12.19.3 Zhejiang Barty Medical Technology Revenue in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026)
  113. 12.19.4 Zhejiang Barty Medical Technology Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  114. 12.19.5 Zhejiang Barty Medical Technology Recent Developments
  115. 12.20 Shenzhen MicroApproach Medical Technology
  116. 12.20.1 Shenzhen MicroApproach Medical Technology Company Information
  117. 12.20.2 Shenzhen MicroApproach Medical Technology Business Overview
  118. 12.20.3 Shenzhen MicroApproach Medical Technology Revenue in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026)
  119. 12.20.4 Shenzhen MicroApproach Medical Technology Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  120. 12.20.5 Shenzhen MicroApproach Medical Technology Recent Developments
  121. 12.21 Beijing Demax Medical Technology
  122. 12.21.1 Beijing Demax Medical Technology Company Information
  123. 12.21.2 Beijing Demax Medical Technology Business Overview
  124. 12.21.3 Beijing Demax Medical Technology Revenue in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026)
  125. 12.21.4 Beijing Demax Medical Technology Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  126. 12.21.5 Beijing Demax Medical Technology Recent Developments
  127. 12.22 JW Medical Systems
  128. 12.22.1 JW Medical Systems Company Information
  129. 12.22.2 JW Medical Systems Business Overview
  130. 12.22.3 JW Medical Systems Revenue in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026)
  131. 12.22.4 JW Medical Systems Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  132. 12.22.5 JW Medical Systems Recent Developments
  133. 12.23 SINOMED
  134. 12.23.1 SINOMED Company Information
  135. 12.23.2 SINOMED Business Overview
  136. 12.23.3 SINOMED Revenue in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026)
  137. 12.23.4 SINOMED Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  138. 12.23.5 SINOMED Recent Developments
  139. 12.24 Kinhely Bio-Tech
  140. 12.24.1 Kinhely Bio-Tech Company Information
  141. 12.24.2 Kinhely Bio-Tech Business Overview
  142. 12.24.3 Kinhely Bio-Tech Revenue in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026)
  143. 12.24.4 Kinhely Bio-Tech Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  144. 12.24.5 Kinhely Bio-Tech Recent Developments
  145. 12.25 Shandong Huaan Biotechnology
  146. 12.25.1 Shandong Huaan Biotechnology Company Information
  147. 12.25.2 Shandong Huaan Biotechnology Business Overview
  148. 12.25.3 Shandong Huaan Biotechnology Revenue in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026)
  149. 12.25.4 Shandong Huaan Biotechnology Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  150. 12.25.5 Shandong Huaan Biotechnology Recent Developments
  151. 12.26 Blue Sail Medical
  152. 12.26.1 Blue Sail Medical Company Information
  153. 12.26.2 Blue Sail Medical Business Overview
  154. 12.26.3 Blue Sail Medical Revenue in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026)
  155. 12.26.4 Blue Sail Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  156. 12.26.5 Blue Sail Medical Recent Developments
  157. 12.27 Shanghai Bio-heart Biological Technology
  158. 12.27.1 Shanghai Bio-heart Biological Technology Company Information
  159. 12.27.2 Shanghai Bio-heart Biological Technology Business Overview
  160. 12.27.3 Shanghai Bio-heart Biological Technology Revenue in Percutaneous Coronary Intervention (PCI) Treatment Instruments Business (2021-2026)
  161. 12.27.4 Shanghai Bio-heart Biological Technology Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  162. 12.27.5 Shanghai Bio-heart Biological Technology Recent Developments
13 Report Conclusion
    14 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst